whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients

Experts are now debating whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients.

This comes from early results of the big "ACCORD" trial.

It was expected to show that intensive control of glucose, lipids, or blood pressure would IMPROVE outcomes in type 2 diabetes patients at high cardiovascular risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote